Life Sciences

InnoMed receives FDA warning letter for alleged GMP violations

Device Regulation Alert: Safety, Compliance and Reimbursement News, February 2, 2009

InnoMed failed to abide by current Good Manufacturing Practices (GMPs) at its Coconut Creek, FL, facility, according to an FDA warning letter.

Post a Comment





Please enter your comment below:


Please enter the text below:


Most Popular